VivoSim Labs
VIVS
30 hedge funds and large institutions have $1.15M invested in VivoSim Labs in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 9 reducing their positions, and 4 closing their positions.
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
17% more capital inflows, than outflows
Capital inflows: $204K | Capital outflows: $175K
0.34% more ownership
Funds ownership: 15.89% → 16.22% (+0.34%)
0% more funds holding
Funds holding: 30 → 30 (0)
67% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 9
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Armistice Capital
New York
|
+$178K |
| 2 |
Wedbush Securities
Los Angeles,
California
|
+$7.94K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$613 |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$198 |
| 5 |
Cullen/Frost Bankers
San Antonio,
Texas
|
+$10 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$98.3K |
| 2 |
PGCM
Prescott Group Capital Management
Tulsa,
Oklahoma
|
-$56.4K |
| 3 |
Two Sigma Securities
New York
|
-$7.72K |
| 4 |
Renaissance Technologies
New York
|
-$5.23K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$2.09K |
VIVS Hedge Fund Activity: Q4 2024 in Review
30 of the 7,628 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q4 2024, worth a combined $1.15M — down 7.7% from $1.24M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new VIVS positions and 4 closed out — a net gain of 1 holder — while 3 added to existing stakes and 9 trimmed.
The largest buyer was Armistice Capital, adding an estimated $178K. The largest seller was Vanguard Group, cutting an estimated $98.3K.
- 30 institutional investors held VivoSim Labs (VIVS) as of Q4 2024, unchanged from Q3 2024.
- Funds reported $1.15M of VivoSim Labs stock for Q4 2024, down 7.7% quarter-over-quarter.
- 5 funds opened new VivoSim Labs positions in Q4 2024 and 4 closed out, a net change of +1 holder.
- The largest VivoSim Labs buyer in Q4 2024 was Armistice Capital, an estimated $178K added.
- The largest VivoSim Labs seller in Q4 2024 was Vanguard Group, an estimated $98.3K sold.
Based on aggregated 13F filings for Q4 2024.